|
RIN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.989900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.601800E-02 |
| Normal-vs-Stage2 |
7.505000E-01 |
| Normal-vs-Stage3 |
4.785600E-02 |
| Normal-vs-Stage4 |
3.869400E-01 |
| Stage1-vs-Stage2 |
3.404200E-01 |
| Stage1-vs-Stage3 |
5.401200E-01 |
| Stage1-vs-Stage4 |
7.185000E-01 |
| Stage2-vs-Stage3 |
2.121800E-01 |
| Stage2-vs-Stage4 |
6.448600E-01 |
| Stage3-vs-Stage4 |
4.670600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.449800E-02 |
| Normal-vs-AfricanAmerican |
3.236500E-02 |
| Normal-vs-Asian |
3.898600E-01 |
| Caucasian-vs-AfricanAmerican |
1.851980E-01 |
| Caucasian-vs-Asian |
5.412200E-01 |
| AfricanAmerican-vs-Asian |
1.343590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.030790E-01 |
| Normal-vs-Female |
7.479800E-02 |
| Male-vs-Female |
8.611600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.970100E-02 |
| Normal-vs-Age(41-60Yrs) |
9.958200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.221000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.871000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.724200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.247000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.056800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.432200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.001800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.414400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.854200E-01 |
| Classical-VS-Follicular |
2.62810000428715E-08 |
| Classical-VS-Other |
3.330200E-01 |
| Classical-VS-Normal |
1.696700E-03 |
| Tall-VS-Follicular |
8.046500E-04 |
| Tall-VS-Other |
3.563600E-01 |
| Tall-VS-Normal |
3.183800E-02 |
| Follicular-VS-Other |
4.079800E-01 |
| Follicular-VS-Normal |
5.979800E-02 |
| Other-VS-Normal |
9.495200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.159400E-01 |
| Normal-vs-N1 |
9.103200E-01 |
| N0-vs-N1 |
4.556600E-01 |
|
|
